// App-Quantinova.ai

TPS658 : A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral bisphosphonate treatment on bone mineral density in osteopenic women receiving adjuvant aromatase inhibitors: Interim analysis of "BONADIUV" trial.

Researchers

Presenter

  • Vieri Scotti

Principal Investigators

  • Icro Meattini

  • Carla De Luca Cardillo

  • Lorenzo Livi

  • Sara Cecchini

  • Maria Laura De Feo

  • Calogero Saieva

Medical Centers

  • ISPO Florence Cancer Center, Florence, Italy

  • Empoli Hospital, Empoli, ItalyFlorence University Hospital, Florence, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Solid malignancies

  • Inflammatory Arthritis

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Ibandronic acid

  • Ergocalciferol

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved